Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed Nov 9, 2023 · 10-Q · 40 days after period end · 0000950170-23-062028
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Net Income | -$7.11M | -$13.08M | -$6.69M | -$3.76M |
| EPS Diluted | -$0.34 | -$1.35 | -$0.71 | -$1.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Sep 30, 2023 · filed Nov 9, 2023 · 40 d after period end
